Asklepios Kliniken GmbH & Co. KGaA
2
Dr. Carl June and Dr. Michel Sadelain are being awarded the Broermann Medical Innovation Award 2025
more
Stories about Genetik
- 2
New Endoscopy Technology Enables Early Detection of Esophageal Cancer
more Therapeutic Vaccine for Chronic Hepatitis B Enters First Clinical Trial in Patients
more- 2
New Label-Free Imaging Tracks Cancer Treatment in Single Cells
more Fraunhofer-Institut für Produktionstechnologie IPT
Transforming personalized medicine with AI-driven CAR-T manufacturing: Automated CAR-T cell production platform is ready for production
more- 3
Key technology for bioprocesses
more
Biomay Obtains FDA Approval for Manufacturing of Cas9 Nuclease at Headquarters Site
moreEngineering Smart Delivery for Gene Editors
more- 2
GEA presents the kytero® 10, the world's smallest single use disk stack centrifuge
more New Knowledge Portal Adiposetissue.org Enhances Obesity and Metabolism Research with Centralized Data
moreLTS Lohmann Therapie-Systeme AG
LTS wins funding from BARDA’s Patch Forward Prize Competition for two partnerships
moreSCP-Nano: A New Technology to Visualize Nanocarriers in Cells and Tissues
more
RHEACELL receives EMA approval for allo-APZ2-CVU Phase 3 trial in chronic venous ulcers
moreMaria-Elena Torres-Padilla Honored With the Leibniz Prize 2025
moreInceptor Regulates Insulin Homeostasis: A New Approach for Diabetes Therapies
moreRHEACELL announces FDA approval for Phase 3 study in refractory, non-curable CVU
moreNew Study: Father's Diet Before Conception Influences Children's Health
moreAdvanced Brain Science Without Coding Expertise
more
Scientists Reveal Adipocyte's Metabolic Role and Identify Treatment Targets
more- 4
FDX Fluid Dynamix and Fraunhofer IPK to Collaborate with Lonza on Novel Nanoparticle Formulation Technology Platform FDmiX
more Research Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease‘
moreRising Focus on 'Inceptor' as a Type 2 Diabetes Therapeutic Target
moreWhat Our Genetic Information Tells Us About Type 2 Diabetes Risk and Complications
moreStrengthening the Direct Sales and Service System for Business Expansion in Italy
One documentmore
Biomay Announces its Successful Support of Approval of First CRISPR/Cas9-based Therapy
moreCells of the Future: A Key To Reprogramming Cell Identities
moreNew Source of Stem Cells in Injury-Affected Brains of Patients
moreFraunhofer-Institut für Produktionstechnologie IPT
Pooling expertise: Fraunhofer IPT and Harro Höfliger cooperate in the manufacturing of ATMP production systems
moreBiomay Announces Expansion of GMP-Facilities to Offer mRNA Manufacturing and Aseptic Filling Services
moreRHEACELL announces “First Patient In”: EB-Haus in Salzburg, Austria starts pivotal study for stem cell therapy for severe forms of Epidermolysis bullosa that is longed for by those affected
more
12Next